GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Median PS Value

Dr Lalchandani Labs (BOM:541299) Median PS Value : ₹0.00 (As of Sep. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Dr Lalchandani Labs's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹11.113. Dr Lalchandani Labs's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₹0.00.

As of today (2024-09-21), Dr Lalchandani Labs's share price is ₹19.80. Dr Lalchandani Labs's Median PS Value is ₹0.00. Therefore, Dr Lalchandani Labs's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Dr Lalchandani Labs's Median PS Value or its related term are showing as below:

BOM:541299's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.94
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Dr Lalchandani Labs Median PS Value Historical Data

The historical data trend for Dr Lalchandani Labs's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Median PS Value Chart

Dr Lalchandani Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dr Lalchandani Labs's Median PS Value

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Price-to-Median-PS-Value falls into.



Dr Lalchandani Labs Median PS Value Calculation

Dr Lalchandani Labs's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=11.113*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹11.113.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Dr Lalchandani Labs's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=19.80/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs Median PS Value Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs Headlines

No Headlines